These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11068750)

  • 1. Quantitation of major histocompatibility complex antigen endocytosis using capture ELISA.
    Turvy DN; Blum JS
    Methods Mol Biol; 2001; 156():57-65. PubMed ID: 11068750
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection of biotinylated cell surface receptors and MHC molecules in a capture ELISA: a rapid assay to measure endocytosis.
    Turvy DN; Blum JS
    J Immunol Methods; 1998 Mar; 212(1):9-18. PubMed ID: 9671148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presentation of antigen and MHC-restricted unresponsiveness.
    Ríhová B
    Folia Biol (Praha); 1995; 41(3-4):140-62. PubMed ID: 7589711
    [No Abstract]   [Full Text] [Related]  

  • 4. Intracellular routes for antigen processing and presentation.
    Brodsky FM
    Res Immunol; 1991; 142(5-6):453-8. PubMed ID: 1754720
    [No Abstract]   [Full Text] [Related]  

  • 5. The recognition of MHC molecules by gamma delta T cells.
    Schild H; Chien YH
    Behring Inst Mitt; 1994 Jul; (94):113-23. PubMed ID: 7998905
    [No Abstract]   [Full Text] [Related]  

  • 6. Cross-presentation of glycoprotein 96-associated antigens on major histocompatibility complex class I molecules requires receptor-mediated endocytosis.
    Singh-Jasuja H; Toes RE; Spee P; Münz C; Hilf N; Schoenberger SP; Ricciardi-Castagnoli P; Neefjes J; Rammensee HG; Arnold-Schild D; Schild H
    J Exp Med; 2000 Jun; 191(11):1965-74. PubMed ID: 10839811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional analysis of antigen processing and major histocompatibility complex class II-restricted presentation.
    Lich JD; Blum JS
    Methods Mol Biol; 2001; 156():49-56. PubMed ID: 11068749
    [No Abstract]   [Full Text] [Related]  

  • 8. [Brief survival guide in a hostile environment: molecular mechanisms in the recognition of infectious agents].
    Siegrist CA
    Rev Med Suisse Romande; 1996 May; 116(5):357-65. PubMed ID: 8693272
    [No Abstract]   [Full Text] [Related]  

  • 9. Localization and characterization of major histocompatibility complex class II-positive cells in the posterior segment of the eye: implications for induction of autoimmune uveoretinitis.
    Forrester JV; McMenamin PG; Holthouse I; Lumsden L; Liversidge J
    Invest Ophthalmol Vis Sci; 1994 Jan; 35(1):64-77. PubMed ID: 8300365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of major histocompatibility complex molecules in rodent retina. Immunohistochemical study.
    Zhang J; Wu GS; Ishimoto S; Pararajasegaram G; Rao NA
    Invest Ophthalmol Vis Sci; 1997 Aug; 38(9):1848-57. PubMed ID: 9286275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation.
    Germain RN
    Cell; 1994 Jan; 76(2):287-99. PubMed ID: 8293464
    [No Abstract]   [Full Text] [Related]  

  • 12. How T cells see antigen.
    Grey HM; Sette A; Buus S
    Sci Am; 1989 Nov; 261(5):56-64. PubMed ID: 2530628
    [No Abstract]   [Full Text] [Related]  

  • 13. Lack of dependence of dendritic cell replacement in accepted rat renal allograft recipients upon a class II MHC disparity.
    Olivier WA; Sanfilippo F
    Transplantation; 1991 Jun; 51(6):1315-7. PubMed ID: 2048211
    [No Abstract]   [Full Text] [Related]  

  • 14. Delivery of exogenous antigen into the major histocompatibility complex class I and class II pathways by electroporation.
    Li Y; Ke Y; Gottlieb PD; Kapp JA
    J Leukoc Biol; 1994 Nov; 56(5):616-24. PubMed ID: 7525819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathways of viral antigen processing and presentation to CTL: defined by the mode of virus entry?
    Long EO; Jacobson S
    Immunol Today; 1989 Feb; 10(2):45-8. PubMed ID: 2665772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendritic cells: open for presentation business.
    Saveanu L; van Endert P
    Nat Immunol; 2005 Jan; 6(1):7-8. PubMed ID: 15611772
    [No Abstract]   [Full Text] [Related]  

  • 17. Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens.
    Schirrmacher V; Schild HJ; Gückel B; von Hoegen P
    Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():311-26. PubMed ID: 7901150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of peptide-MHC class II complexes on the surface of intact cells.
    Busch R; Rothbard JB
    J Immunol Methods; 1990 Nov; 134(1):1-22. PubMed ID: 2230144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring antigen-specific T cells using MHC-Ig dimers.
    Schneck JP; Slansky JE; O'Herrin SM; Greten TF
    Curr Protoc Immunol; 2001 May; Chapter 17():Unit 17.2. PubMed ID: 18432743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presentation of exogenous antigen with class I major histocompatibility complex molecules.
    Rock KL; Gamble S; Rothstein L
    Science; 1990 Aug; 249(4971):918-21. PubMed ID: 2392683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.